Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Invite MembersWorkspace SettingsUpgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Thesis

Thesis

Thesis is a company that creates tailor-made nootropic products for individuals on the basis of improving various cognitive functions.

OverviewStructured DataIssuesContributorsActivity
Contents

Thesis is a nootropics company that creates tailor-made products for individuals based on their lifestyles and what cognitive or cerebral function they're looking to improve. The user fills out a questionnaire on some of their health and lifestyle details, like weight, gender, age, level of alcohol consumption, and frequency of exercise. Then the results are emailed to the user, who can decide to purchase their first curated box. Thesis was founded by Dan Freed and Adam Greenfeld.

Nootropics

Nootropics are pharmaceutical drugs or other substances that claim to enhance cognitive and cerebral functions, such as memory, energy levels, and motivation. Types of nootropics include caffeine, Adderall, creatine, and ginkgo biloba.

Thesis states that "every ingredient in our blends undergoes a rigorous, multi-step evaluation to ensure they meet our ethical, medical, and legal standards. We select only well-established ingredients shown to be effective and safe based on clinical trials, and all of our formulas are third-party tested for purity." The exact ingredients they use are not listed, but categorized in "nootropics and functional mushrooms," "choline sources," and "vitamins and adaptogens".

Timeline

April 3, 2020
Thesis raises a $7,700,000 seed round from Paradigm.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

takethesis.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Nootropic
Nootropic
Biohacking
Biohacking
Blockchain and cryptocurrency
Blockchain and cryptocurrency
Location
New York City
New York City
New York
New York
B2X
B2C
B2C
CEO
Dan Freed
Dan Freed
Founder
Adam Greenfeld
Adam Greenfeld
Dan Freed
Dan Freed
Pitchbook URL
pitchbook.com/profiles...279867-52
Full Address
902 Broadway Floor 6 New York, NY 10010
Investors
XRC Labs
XRC Labs
Paradigm
Paradigm
Fenbushi Capital
Fenbushi Capital
Email Address
hello@takethesis.com
Phone Number
+16466473599
Total Funding Amount (USD)
7,700,000
Latest Funding Round Date
April 3, 2020
Competitors
Noots
Noots
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries
Accelerated Intelligence
Accelerated Intelligence
HVMN
HVMN
Nootropics.com
Nootropics.com
Powder City
Powder City
Onnit Labs
Onnit Labs
‌
Alternascript
...
Latest Funding Type
Seed round
Seed round

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
7,700,000
Funding Type
Seed round
Seed round
Funding Round Amount (USD)
7,700,000
Funding Round Date
April 3, 2020
Investment
Paradigm
Paradigm
TikTok URL
tiktok.com/@takethesis
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocolChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.